Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Correction: Factors associated with discontinuation of biologics in patients with inflammatory arthritis in remission: data from the BIOBADASER registryArthritis research & therapy, 2023-10, Vol.25 (1), p.210-210, Article 210 [Peer Reviewed Journal]COPYRIGHT 2023 BioMed Central Ltd. ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-023-03194-5Full text available |
|
2 |
Material Type: Article
|
PrefaceCancer and metastasis reviews, 2023-03, Vol.42 (1), p.3 [Peer Reviewed Journal]COPYRIGHT 2023 Springer ;ISSN: 0167-7659 ;EISSN: 1573-7233 ;DOI: 10.1007/s10555-023-10093-3Full text available |
|
3 |
Material Type: Article
|
PrefaceCancer and metastasis reviews, 2023-03, Vol.42 (1), p.3 [Peer Reviewed Journal]COPYRIGHT 2023 Springer ;ISSN: 0167-7659 ;EISSN: 1573-7233 ;DOI: 10.1007/s10555-023-10093-3Full text available |
|
4 |
Material Type: Article
|
PrefaceCancer and metastasis reviews, 2023-03, Vol.42 (1), p.3 [Peer Reviewed Journal]COPYRIGHT 2023 Springer ;ISSN: 0167-7659 ;EISSN: 1573-7233 ;DOI: 10.1007/s10555-023-10093-3Full text available |
|
5 |
Material Type: Article
|
FROM THE EDITOR IN CHIEF: Days of Future PastThe American journal of managed care, 2023-10, Vol.29 (8) [Peer Reviewed Journal]COPYRIGHT 2023 Intellisphere, LLC ;ISSN: 1088-0224 ;EISSN: 1936-2692Full text available |
|
6 |
Material Type: Article
|
Correction to "Diagnosis and management of eosinophilic esophagitis"Canadian Medical Association journal (CMAJ), 2024-03, Vol.196 (8), p.E268-E268 [Peer Reviewed Journal]COPYRIGHT 2024 CMA Impact Inc. ;2024 CMA Impact Inc. or its licensors 2024 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.240239 ;PMID: 38438156Full text available |
|
7 |
Material Type: Article
|
Extraction, Purification, and Elucidation of Six Ginkgol Homologs from IGinkgo biloba/I Sarcotesta and Evaluation of Their Anticancer ActivitiesMolecules (Basel, Switzerland), 2022-11, Vol.27 (22) [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules27227777Full text available |
|
8 |
Material Type: Article
|
Coverage From ACCC 2023 Spring Business SummitThe American journal of managed care, 2023-04 [Peer Reviewed Journal]COPYRIGHT 2023 Intellisphere, LLC ;ISSN: 1088-0224 ;EISSN: 1936-2692Full text available |
|
9 |
Material Type: Article
|
Extraction of the Anticancer and Antimicrobial Agent, Prodigiosin, from IVibrio gazogenes/I PB1 and Its Identification by 1D and 2D NMRMolecules (Basel, Switzerland), 2022-09, Vol.27 (18) [Peer Reviewed Journal]COPYRIGHT 2022 MDPI AG ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules27186030Full text available |
|
10 |
Material Type: Article
|
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deteriorationPloS one, 2023-12, Vol.18 (12), p.e0295838 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0295838Full text available |
|
11 |
Material Type: Article
|
Reasons for stopping Pressurized IntraPeritoneal Aerosol ChemotherapyPloS one, 2023-11, Vol.18 (11), p.e0287785 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0287785Full text available |
|
12 |
Material Type: Article
|
Patient safety charterBulletin of the World Health Organization, 2023-10, Vol.101 (10), p.621 [Peer Reviewed Journal]COPYRIGHT 2023 World Health Organization ;ISSN: 0042-9686 ;EISSN: 1564-0604Full text available |
|
13 |
Material Type: Article
|
Correction to "Diagnosis and management of patients with polyneuropathy"Canadian Medical Association journal (CMAJ), 2023-03, Vol.195 (11), p.E415-E415 [Peer Reviewed Journal]COPYRIGHT 2023 CMA Impact Inc. ;2023 CMA Impact Inc. or its licensors 2023 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.230264 ;PMID: 37072238Full text available |
|
14 |
Material Type: Article
|
Content validity of the Scoliosis Research Society questionnairePloS one, 2023-05, Vol.18 (5), p.e0285538 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0285538Full text available |
|
15 |
Material Type: Article
|
Association between oral frailty and cystatin C-related indices-A questionnairePloS one, 2023-04, Vol.18 (4), p.e0283803 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0283803Full text available |
|
16 |
Material Type: Article
|
Perceptions, attitudes, and behaviors of asthma patients towards the use of short-acting [beta].sub.2-agonists: A systematic reviewPloS one, 2023-04, Vol.18 (4), p.e0283876 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0283876Full text available |
|
17 |
Material Type: Article
|
Syndrome d’hypersensibilité à l’allopurinolCanadian Medical Association journal (CMAJ), 2023-07, Vol.195 (27), p.E944-E944 [Peer Reviewed Journal]COPYRIGHT 2023 CMA Impact Inc. ;2023 CMA Impact Inc. or its licensors 2023 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.221575-f ;PMID: 37460122Full text available |
|
18 |
Material Type: Article
|
Infection with SARS-CoV-2 variant GammaPloS one, 2023-03, Vol.18 (3), p.e0283085 [Peer Reviewed Journal]COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0283085Full text available |
|
19 |
Material Type: Article
|
A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating [kappa]-opioid antagonism as a treatment for anhedoniaNature medicine, 2020-05, Vol.26 (5), p.760 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0806-7Full text available |
|
20 |
Material Type: Article
|
Un accès équitable aux soins contre le cancer pour les personnes noires au CanadaCanadian Medical Association journal (CMAJ), 2023-01, Vol.195 (1), p.E51-E55 [Peer Reviewed Journal]COPYRIGHT 2023 CMA Impact Inc. ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.212076-fFull text available |